Potentially Inappropriate Use of Opioids in the Management of Migraine in Colombia

Research objective: To identify the frequency of opioid use in a group of patients diagnosed with migraine in Colombia. Methods: Study of a retrospective cohort of patients with a diagnosis of migraine and a first prescription of antimigraine drugs from emergency services and a priority outpatient c...

Full description

Bibliographic Details
Main Authors: Manuel E. Machado-Duque, Maria Fernanda Echeverry-Gutiérrez, Andrés Gaviria-Mendoza, Luis F. Valladales-Restrepo, Jorge E. Machado-Alba
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/9/2385
_version_ 1827727049258696704
author Manuel E. Machado-Duque
Maria Fernanda Echeverry-Gutiérrez
Andrés Gaviria-Mendoza
Luis F. Valladales-Restrepo
Jorge E. Machado-Alba
author_facet Manuel E. Machado-Duque
Maria Fernanda Echeverry-Gutiérrez
Andrés Gaviria-Mendoza
Luis F. Valladales-Restrepo
Jorge E. Machado-Alba
author_sort Manuel E. Machado-Duque
collection DOAJ
description Research objective: To identify the frequency of opioid use in a group of patients diagnosed with migraine in Colombia. Methods: Study of a retrospective cohort of patients with a diagnosis of migraine and a first prescription of antimigraine drugs from emergency services and a priority outpatient clinic. Sociodemographic, clinical, and pharmacological variables were identified; a 12-month follow-up was carried out to identify the use of a new opioid. Results: A total of 6309 patients with a diagnosis of migraine were identified, with a mean age of 35.5 ± 12.3 years, of which 81.3% were women. Nonsteroidal anti-inflammatory drugs (51.1%) were the most frequently prescribed medications, followed by ergotamine + caffeine (31.3%), acetaminophen (15.05%), and acetaminophen + codeine (14.4%). At the time of the index, 1300 (20.6%) patients received some opioid. During the follow-up, a total of 1437 (22.8%) patients received a new opioid, of which 31.8% belonged to the group that received an initial opioid and 20.4% to the group that did not receive one, which was statistically significant (OR:1.81; 95%CI:1.58–2.07; <i>p</i> < 0.001). Conclusions: The frequent use of opioids in the management of migraines is potentially inappropriate and can lead to problems of tolerance, abuse and dependence. This combined with the low prescription of triptans, offers an opportunity for improvements in medical practice.
first_indexed 2024-03-10T22:59:56Z
format Article
id doaj.art-05d8c043d96e48319250548944c80524
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-10T22:59:56Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-05d8c043d96e48319250548944c805242023-11-19T09:40:34ZengMDPI AGBiomedicines2227-90592023-08-01119238510.3390/biomedicines11092385Potentially Inappropriate Use of Opioids in the Management of Migraine in ColombiaManuel E. Machado-Duque0Maria Fernanda Echeverry-Gutiérrez1Andrés Gaviria-Mendoza2Luis F. Valladales-Restrepo3Jorge E. Machado-Alba4Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira 660003, ColombiaGrupo de Investigación Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de Las Américas, Pereira 660003, ColombiaGrupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira 660003, ColombiaGrupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira 660003, ColombiaGrupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira 660003, ColombiaResearch objective: To identify the frequency of opioid use in a group of patients diagnosed with migraine in Colombia. Methods: Study of a retrospective cohort of patients with a diagnosis of migraine and a first prescription of antimigraine drugs from emergency services and a priority outpatient clinic. Sociodemographic, clinical, and pharmacological variables were identified; a 12-month follow-up was carried out to identify the use of a new opioid. Results: A total of 6309 patients with a diagnosis of migraine were identified, with a mean age of 35.5 ± 12.3 years, of which 81.3% were women. Nonsteroidal anti-inflammatory drugs (51.1%) were the most frequently prescribed medications, followed by ergotamine + caffeine (31.3%), acetaminophen (15.05%), and acetaminophen + codeine (14.4%). At the time of the index, 1300 (20.6%) patients received some opioid. During the follow-up, a total of 1437 (22.8%) patients received a new opioid, of which 31.8% belonged to the group that received an initial opioid and 20.4% to the group that did not receive one, which was statistically significant (OR:1.81; 95%CI:1.58–2.07; <i>p</i> < 0.001). Conclusions: The frequent use of opioids in the management of migraines is potentially inappropriate and can lead to problems of tolerance, abuse and dependence. This combined with the low prescription of triptans, offers an opportunity for improvements in medical practice.https://www.mdpi.com/2227-9059/11/9/2385opioid analgesicsmigrainedrug-related side effectsadverse reactionsheadachepharmacoepidemiology
spellingShingle Manuel E. Machado-Duque
Maria Fernanda Echeverry-Gutiérrez
Andrés Gaviria-Mendoza
Luis F. Valladales-Restrepo
Jorge E. Machado-Alba
Potentially Inappropriate Use of Opioids in the Management of Migraine in Colombia
Biomedicines
opioid analgesics
migraine
drug-related side effects
adverse reactions
headache
pharmacoepidemiology
title Potentially Inappropriate Use of Opioids in the Management of Migraine in Colombia
title_full Potentially Inappropriate Use of Opioids in the Management of Migraine in Colombia
title_fullStr Potentially Inappropriate Use of Opioids in the Management of Migraine in Colombia
title_full_unstemmed Potentially Inappropriate Use of Opioids in the Management of Migraine in Colombia
title_short Potentially Inappropriate Use of Opioids in the Management of Migraine in Colombia
title_sort potentially inappropriate use of opioids in the management of migraine in colombia
topic opioid analgesics
migraine
drug-related side effects
adverse reactions
headache
pharmacoepidemiology
url https://www.mdpi.com/2227-9059/11/9/2385
work_keys_str_mv AT manuelemachadoduque potentiallyinappropriateuseofopioidsinthemanagementofmigraineincolombia
AT mariafernandaecheverrygutierrez potentiallyinappropriateuseofopioidsinthemanagementofmigraineincolombia
AT andresgaviriamendoza potentiallyinappropriateuseofopioidsinthemanagementofmigraineincolombia
AT luisfvalladalesrestrepo potentiallyinappropriateuseofopioidsinthemanagementofmigraineincolombia
AT jorgeemachadoalba potentiallyinappropriateuseofopioidsinthemanagementofmigraineincolombia